Last Update: Oct 23, 2024
A Phase III, Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (VAYHIT1)
ClinicalTrials.gov Identifier:
Novartis Reference Number:CVAY736I12301
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation.

Study Description

The purpose of this study is to evaluate the effect of two different doses of ianalumab
versus placebo in addition to first-line corticosteroids in maintaining platelet count
≥30 G/L in adult participants with primary ITP. This is a multi-center, randomized, double-blind Phase 3 study to assess the efficacy and
safety of two different doses of ianalumab compared to placebo in adults with primary ITP
(platelets count <30 G/L) who require first-line standard-of-care corticosteroids.

After completion of the screening period, the participants will enter the randomized
treatment period (ianalumab/placebo with standard of care corticosteroids).

After the treatment period, all participants will enter the follow-up period to be
monitored for efficacy and safety or safety only depending on how they respond to the
study treatment.

Primary Immune Thrombocytopenia (ITP)
Phase3
Recruiting
225
Mar 06, 2023
Dec 18, 2028
All
18 Years - (Adult, Older Adult)

Interventions

Drug

Corticosteroids

Oral or parental (if clinically justified)
Biological

Ianalumab

Intravenous infusion, prepared from concentrate solution
Drug

Placebo

Intravenous infusion, prepared from matching placebo

Eligibility Criteria

Inclusion Criteria:

- Signed informed consent prior to participation in the study.

- Male or female participants aged 18 years and older on the day of signing informed
consent

- Primary ITP diagnosed within 3 months before initiating first-line ITP therapy
(corticosteroids, IVIG)

- Platelet count below 30 G/L before starting any first-line ITP therapy
(corticosteroids, IVIG)

- Response (platelet count >=50 G/L) to corticosteroids (+/- IVIG) at any time prior
to randomization. Note: Platelet count measured within 7 days of platelet
transfusion will not be considered as response.

Key Exclusion Criteria:

- Evans syndrome or any other cytopenia (patients with anemia related to bleeding or
iron deficiency are eligible)

- Current life-threatening bleeding

- Previous ITP treatment, including splenectomy, except for corticosteroids and/or
IVIG initiated as first-line therapy for up to 28 days before randomization and
rescue corticosteroids and/or IVIG given prior to confirmed diagnosis of primary ITP
.

- Prior use of B-cell depleting therapy (e.g., rituximab).

- Absolute neutrophil count below 1.0 G/L at randomization

- Participants with concurrent coagulation disorders and/or receiving anti-platelet or
anticoagulant medication with an exemption of low dose of acetylsalicylic acid

Other protocol-defined Inclusion/Exclusion may apply.

Novartis Investigative Site

Recruiting

Caba,Buenos Aires,C1414drk,Argentina

Novartis Investigative Site

Recruiting

Ciudad Autonoma de Bs As,Buenos Aires,C1015abo,Argentina

Novartis Investigative Site

Recruiting

Tucuman,San Miguel De Tucuman,4000,Argentina

Novartis Investigative Site

Recruiting

Buenos aires,C1039aac,Argentina

Novartis Investigative Site

Recruiting

Cordoba,5000,Argentina

Novartis Investigative Site

Recruiting

Caba,Buenos Aires,C1280aeb,Argentina

Novartis Investigative Site

Recruiting

Clayton,Victoria,3168,Australia

Novartis Investigative Site

Recruiting

Melbourne,Victoria,3004,Australia

Novartis Investigative Site

Recruiting

Canberra,Australian Capital Territory,2605,Australia

Novartis Investigative Site

Recruiting

Wooloongabba,Queensland,4102,Australia

Novartis Investigative Site

Recruiting

Wien,1140,Austria

Novartis Investigative Site

Recruiting

Innsbruck,Tyrol,6020,Austria

Novartis Investigative Site

Recruiting

Salzburg,5020,Austria

Novartis Investigative Site

Recruiting

Brasschaat,2930,Belgium

Novartis Investigative Site

Recruiting

Brugge,8000,Belgium

Novartis Investigative Site

Recruiting

Leuven,3000,Belgium

Novartis Investigative Site

Recruiting

Roeselare,8800,Belgium

Novartis Investigative Site

Recruiting

Sofia,1413,Bulgaria

Novartis Investigative Site

Recruiting

Sofia,1431,Bulgaria

Novartis Investigative Site

Recruiting

Varna,9010,Bulgaria

Novartis Investigative Site

Recruiting

Plovdiv,4002,Bulgaria

Novartis Investigative Site

Recruiting

Xian,Shaanxi,710004,China

Novartis Investigative Site

Recruiting

Luoyang,Henan,471003,China

Novartis Investigative Site

Recruiting

Dalian,116000,China

Novartis Investigative Site

Recruiting

Taiyuan,Shanxi,030001,China

Novartis Investigative Site

Recruiting

Zhengzhou,Henan,450052,China

Novartis Investigative Site

Recruiting

Jinan,250012,China

Novartis Investigative Site

Recruiting

Chengdu,Sichuan,610041,China

Novartis Investigative Site

Recruiting

Wuhan,Hubei,430022,China

Novartis Investigative Site

Recruiting

Shijiazhuang,050000,China

Novartis Investigative Site

Recruiting

Beijing,Beijing,100044,China

Novartis Investigative Site

Recruiting

Kunming,Yunnan,650101,China

Novartis Investigative Site

Recruiting

Changsha,Hunan,410008,China

Novartis Investigative Site

Recruiting

Tianjin,300020,China

Novartis Investigative Site

Recruiting

Chongqing,Chongqing,400010,China

Novartis Investigative Site

Recruiting

Hangzhou,Zhejiang,310003,China

Novartis Investigative Site

Recruiting

Changzhou,Jiangsu,213004,China

Novartis Investigative Site

Recruiting

Guangzhou,Guangdong,510515,China

Novartis Investigative Site

Recruiting

Hangzhou,Zhejiang,310006,China

Novartis Investigative Site

Recruiting

Nanchang,Jiangxi,330006,China

Novartis Investigative Site

Recruiting

Shenzhen,Guangdong,518037,China

Novartis Investigative Site

Recruiting

Bengbu,233004,China

Novartis Investigative Site

Recruiting

Praha 10,100 34,Czechia

Novartis Investigative Site

Recruiting

Praha,12808,Czechia

Novartis Investigative Site

Recruiting

Ostrava,Poruba,708 52,Czechia

Novartis Investigative Site

Recruiting

Brno Bohunice,625 00,Czechia

Novartis Investigative Site

Recruiting

Paris,75014,France

Novartis Investigative Site

Recruiting

Rennes,35043,France

Novartis Investigative Site

Recruiting

Caen,14033,France

Novartis Investigative Site

Recruiting

Chambery cedex,73011,France

Novartis Investigative Site

Recruiting

Le Mans,72000,France

Novartis Investigative Site

Recruiting

Lille,59037,France

Novartis Investigative Site

Recruiting

Hannover,30161,Germany

Novartis Investigative Site

Recruiting

Jena,07740,Germany

Novartis Investigative Site

Recruiting

Dresden,01307,Germany

Novartis Investigative Site

Recruiting

Essen,45147,Germany

Novartis Investigative Site

Recruiting

Frankfurt,60590,Germany

Novartis Investigative Site

Recruiting

Giessen,35392,Germany

Novartis Investigative Site

Recruiting

Greifswald,17475,Germany

Novartis Investigative Site

Recruiting

New Territories,Hong Kong

Novartis Investigative Site

Recruiting

Budapest,H-1083,Hungary

Novartis Investigative Site

Recruiting

Debrecen,4032,Hungary

Novartis Investigative Site

Recruiting

Ahmedabad,Gujarat,380013,India

Novartis Investigative Site

Recruiting

Mumbai,Maharashtra,400012,India

Novartis Investigative Site

Recruiting

Kolkata,West Bengal,700094,India

Novartis Investigative Site

Recruiting

Trieste,TS,34129,Italy

Novartis Investigative Site

Recruiting

Vicenza,VI,36100,Italy

Novartis Investigative Site

Recruiting

Bologna,BO,40138,Italy

Novartis Investigative Site

Recruiting

Firenze,FI,50134,Italy

Novartis Investigative Site

Recruiting

Roma,RM,00168,Italy

Novartis Investigative Site

Recruiting

Matsumoto-city,Nagano,399-8701,Japan

Novartis Investigative Site

Recruiting

Okayama city,Okayama,701-1192,Japan

Novartis Investigative Site

Recruiting

Osaka-city,Osaka,543-8555,Japan

Novartis Investigative Site

Recruiting

Nagakute-city,Aichi,480-1195,Japan

Novartis Investigative Site

Recruiting

Iruma-gun,Saitama,350-0495,Japan

Novartis Investigative Site

Recruiting

Gifu shi,Gifu,500 8513,Japan

Novartis Investigative Site

Recruiting

Chiba,260-0852,Japan

Novartis Investigative Site

Recruiting

Shibukawa-city,Gunma,377-0280,Japan

Novartis Investigative Site

Recruiting

Fukuoka,815-8555,Japan

Novartis Investigative Site

Recruiting

Sapporo,Hokkaido,060-8604,Japan

Novartis Investigative Site

Recruiting

Johor Bahru,80100,Malaysia

Novartis Investigative Site

Recruiting

Kuala Lumpur,56000,Malaysia

Novartis Investigative Site

Recruiting

Penang,10050,Malaysia

Novartis Investigative Site

Recruiting

Selangor,68000,Malaysia

Novartis Investigative Site

Recruiting

Kuching,Sarawak,93586,Malaysia

Novartis Investigative Site

Recruiting

Monterrey,Nuevo Leon,64460,Mexico

Novartis Investigative Site

Recruiting

Ciudad De Mexico,Mexico CP,14080,Mexico

Novartis Investigative Site

Recruiting

Morelia,Michoacan,58260,Mexico

Novartis Investigative Site

Recruiting

Gralum,1714,Norway

Novartis Investigative Site

Recruiting

Bucharest,District 2,022328,Romania

Novartis Investigative Site

Recruiting

Bucharest,030171,Romania

Novartis Investigative Site

Recruiting

Bucuresti,013975,Romania

Novartis Investigative Site

Recruiting

Singapore,S308433,Singapore

Novartis Investigative Site

Recruiting

Singapore,119074,Singapore

Novartis Investigative Site

Recruiting

Singapore,169608,Singapore

Novartis Investigative Site

Recruiting

Murcia,30008,Spain

Novartis Investigative Site

Recruiting

Sevilla,Andalucia,41013,Spain

Novartis Investigative Site

Recruiting

Salamanca,Castilla Y Leon,37007,Spain

Novartis Investigative Site

Recruiting

Barcelona,Catalunya,08035,Spain

Novartis Investigative Site

Recruiting

Madrid,28009,Spain

Novartis Investigative Site

Recruiting

Madrid,28046,Spain

Novartis Investigative Site

Recruiting

Bangkok,10330,Thailand

Novartis Investigative Site

Recruiting

Bangkok,10700,Thailand

Novartis Investigative Site

Recruiting

Chiang Mai,50200,Thailand

Novartis Investigative Site

Recruiting

Edirne,22030,Turkey

Novartis Investigative Site

Recruiting

Istanbul,34214,Turkey

Novartis Investigative Site

Recruiting

Izmir,35100,Turkey

Novartis Investigative Site

Recruiting

Samsun,55139,Turkey

Novartis Investigative Site

Recruiting

Istanbul,TUR,34098,Turkey

Novartis Investigative Site

Recruiting

Aydin,09100,Turkey

Novartis Investigative Site

Recruiting

Leeds,Ls1 3ex,United Kingdom

Novartis Investigative Site

Recruiting

Liverpool,L7 8xp,United Kingdom

Novartis Investigative Site

Recruiting

London,Sw17 0qt,United Kingdom

Novartis Investigative Site

Recruiting

London,W12 0hs,United Kingdom

Novartis Investigative Site

Recruiting

Truro,Cornwall,Tr1 3lj,United Kingdom

Novartis Investigative Site

Recruiting

Nottingham,Ng5 1pb,United Kingdom

Novartis Investigative Site

Recruiting

Birmingham,B15 2th,United Kingdom

Novartis Investigative Site

Recruiting

Southampton,So16 6yd,United Kingdom

Novartis Investigative Site

Recruiting

Glasgow,G31 2er,United Kingdom

Michigan Center of Medical Research

Recruiting

Farmington Hills,Michigan,48334,United States

Faisal Musa

Hematology Oncology Association of Rockland

Recruiting

Nyack,New York,10960,United States

Sung Ho Lee
Marion VanWoudenberg

Texas Oncology

Recruiting

McAllen,Texas,78503,United States

Louise Philipp
Nurul Wahid

Napa Research

Recruiting

Margate,Florida,33063,United States

Emilio Araujo-Mino

Summit Health

Recruiting

Florham Park,New Jersey,07932,United States

David Gallinson

Community Cancer Institute

Recruiting

Clovis,California,93611,United States

Kelly Meehan
Mohammed Bukari

University of Pennsylvania

Recruiting

Philadelphia,Pennsylvania,19104,United States

Adam Cuker
Emmanuel Ndukwudimma

Mayo Clinic Rochester Mayo Clinic Rochester

Recruiting

Rochester,Minnesota,55905,United States

Alexandra Wolanskyj

Cleveland Clinic Foundation .

Recruiting

Cleveland,Ohio,44195,United States

Alan Lichtin
Antonio Wilson

Uni of Chi Medi Ctr Hema and Onco Main Centre

Recruiting

Chicago,Illinois,60637,United States

Michael Drazer
Sara Moellering

Inspira Medical Cent Mullica Hill

Recruiting

Mullica Hill,New Jersey,08062,United States

Catherine Vasquez
Erev Tubb

Mays Cancer Ctr Uthsa Mdacc UTHSCSA

Recruiting

San Antonio,Texas,78229,United States

Elizabeth Bowhay-Carnes

Compassionate Care Res Group Inc

Recruiting

Fountain Valley,California,92708,United States

Eric Lee

Rhode Island Hospital

Recruiting

Providence,Rhode Island,02903,United States

Andrew Hsu

Metro Minnesota CCOP Main Site Address Oncology

Recruiting

Saint Louis Park,Minnesota,55416,United States

Yan Ji

STAT Research Inc Premier Clin Res LLC STAT Res

Recruiting

Dayton,Ohio,45402,United States

Aby Madrigal
Charles Bane

Parkview Research Center .

Recruiting

Fort Wayne,Indiana,46845,United States

Jeffrey Letzer

Community Cancer Trials of Utah

Recruiting

Ogden,Utah,84405,United States

Carl Gray
Sibian Torres

Clinical Research Alliance Research

Recruiting

Lake Success,New York,11042,United States

James D Olimpio
William Krenn

St Vincent Frontier Cancer Center .

Recruiting

Billings,Montana,59102,United States

Amanda Klein
Patrick Cobb

Oncology Care Associates

Recruiting

Bethesda,Maryland,20817,United States

Natalie Bongiorno
Ralph V Boccia

Texas Oncology-Baylor Res Ins

Recruiting

Dallas,Texas,75204,United States

Dominique Marquez
Moshe Yair Levy

University of Colorado Anschutz

Recruiting

Aurora,Colorado,80045,United States

George Gemlyn

INTEGRIS Cancer Institute of Oklahoma Integris South West Med Center

Recruiting

Oklahoma City,Oklahoma,73142,United States

Basgar Alasad
Kellie Larsen-Dyer

Yuma Regional Medical Center

Recruiting

Yuma,Arizona,85349,United States

Abhinav Chandra
Amy Olmeda

Novartis Investigative Site

Recruiting

Hanoi,100000,Vietnam

Novartis Investigative Site

Recruiting

Ho Chi Minh,738000,Vietnam

Worldwide Contacts

If the location of your choosing does not feature any contact detail, please reach out using the information below.

Novartis Pharmaceuticals

Novartis Pharmaceuticals